paclitaxel has been researched along with Germinoma in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 12 (41.38) | 18.2507 |
2000's | 17 (58.62) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brown, JE; Coleman, RE; Goldstraw, P; Hatton, MQ; Melchers, R | 1 |
Driver, D; Giles, C; Harland, SJ; Haynes, R; Kanfer, EJ; McNeish, IA; Newlands, ES; Rustin, GJ; Seckl, MJ | 1 |
Aieta, M; De Giorgi, U; Fochessati, F; Marangolo, M; Paoluzzi, L; Papiani, G; Rosti, G; Valduga, F | 1 |
Boehlke, I; Bokemeyer, C; Hartmann, JT; Kanz, L; Kollmannsberger, C; Kuczyk, M; Metzner, B; Schleicher, J; Schleucher, N; Wierecky, J | 1 |
Hlavatá, Z; Koza, I; Mardiak, J; Mego, M; Obertová, J; Recková, M; Sálek, T; Sycová-Milá, Z | 2 |
Coleman, RE; El-Helw, L | 1 |
Bacik, J; Bajorin, D; Bosl, GJ; Donadio, A; Kondagunta, GV; Marion, S; Motzer, RJ; Sheinfeld, J | 1 |
Fangusaro, J; Finlay, J; Rook, J; Rosser, T | 1 |
Brezinka, C; Hubalek, M; Marth, C; Mueller-Holzner, E; Sergi, C; Smekal-Schindelwig, C; Zeimet, AG | 1 |
Bajorin, DF; Bosl, GJ; Fischer, P; Hutter, HS; Lyn, P; Motzer, RJ; Scher, HI; Schwartz, LH | 1 |
Bajorin, DF; Bosl, GJ; Chou, TC; Hutter, H; Motzer, RJ; Schwartz, L | 1 |
Beyer, J; Bokemeyer, C; Knoche, M; Natt, F; Schmoll, HJ; Souchon, R | 1 |
Arbuck, SG | 1 |
Beyer, J; Bokemeyer, C; Hartmann, JT; Jonas, U; Kanz, L; Kuczyk, MA; Truss, MC | 1 |
Beyer, J; Bokemeyer, C; Harstrick, A; Kohrmann, U; Metzner, B; Ruther, U; Schmoll, HJ; Verbeek, W; Weissbach, L | 1 |
Oliver, RT | 1 |
Bokemeyer, C; Casper, J; Dunn, TA; Grünwald, V | 1 |
Motzer, RJ | 2 |
Engstrom, C; Green, M; Lilenbaum, RC; MacManus, D | 1 |
Adelantado, S; González, P; Iñiguez, C; Larrodé, P; Mayordomo, JI; Morales, F; Trés, A; Yubero, A | 1 |
de Mulder, PH; de Wit, R; Louwerens, M; Rodenhuis, S; Schornagel, J; Verweij, J | 1 |
Bains, M; Bajorin, DF; Bosl, GJ; Flombaum, C; Macapinlac, HA; Mariani, T; Mazumdar, M; Motzer, RJ; Reich, L; Sheinfeld, J; Tong, WP | 1 |
Bacik, J; Bains, M; Bajorin, D; Bosl, GJ; Mariani, T; Mazumdar, M; Motzer, RJ; Sheinfeld, J | 1 |
Beyer, J; Bokemeyer, C; Rick, O; Siegert, W | 1 |
De Giorgi, U; Marangolo, M; Papiani, G; Rosti, G | 1 |
Beyer, J; Rick, O; Siegert, W | 1 |
Catalano, P; Einhorn, LH; Hinton, S; Kuzel, T; Loehrer, PJ; Vaughn, D; Wilding, G | 1 |
7 review(s) available for paclitaxel and Germinoma
Article | Year |
---|---|
Salvage, dose intense and high-dose chemotherapy for the treatment of poor prognosis or recurrent germ cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease-Free Survival; Drug Administration Schedule; Gemcitabine; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Prognosis; Randomized Controlled Trials as Topic; Salvage Therapy | 2005 |
Paclitaxel in germ cell cancer.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Cyclophosphamide; Drug Resistance; Drug Screening Assays, Antitumor; Drug Synergism; Female; Germinoma; Humans; Ifosfamide; Male; Middle Aged; Paclitaxel; Teratocarcinoma; Tumor Cells, Cultured | 1995 |
The role of paclitaxel in chemosensitive urological malignancies: current strategies in bladder cancer and testicular germ-cell tumors.
Topics: Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Germinoma; Humans; Male; Paclitaxel; Testicular Neoplasms; Urinary Bladder Neoplasms | 1996 |
Future trials in germ cell malignancy (GCM) of the testis.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Clinical Trials as Topic; Decision Making; Etoposide; Forecasting; Genetic Therapy; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Orchiectomy; Paclitaxel; Patient Participation; Quality of Life; Risk Factors; Safety; Salvage Therapy; Seminoma; Testicular Neoplasms | 1997 |
Paclitaxel (Taxol) combination therapy for resistant germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Germinoma; Humans; Male; Paclitaxel; Remission Induction; Salvage Therapy; Testicular Neoplasms | 2000 |
Salvage chemotherapy in relapsed germ cell tumors.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Paclitaxel; Taxoids; Testicular Neoplasms; Vinblastine | 2001 |
The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patients.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carboplatin; Cisplatin; Clinical Trials, Phase I as Topic; Clinical Trials, Phase II as Topic; Cyclophosphamide; Etoposide; Europe; Forecasting; Gastrointestinal Diseases; Germinoma; Hematologic Diseases; Hematopoietic Stem Cell Transplantation; Hepatic Veno-Occlusive Disease; Humans; Ifosfamide; Kidney Diseases; Male; Multicenter Studies as Topic; Neoplasms, Second Primary; Paclitaxel; Prognosis; Randomized Controlled Trials as Topic; Salvage Therapy; Thiotepa; Transplantation Conditioning; Transplantation, Autologous; Treatment Outcome | 2002 |
14 trial(s) available for paclitaxel and Germinoma
Article | Year |
---|---|
Paclitaxel-containing high-dose chemotherapy for relapsed or refractory testicular germ cell tumours.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Drug Resistance, Neoplasm; Etoposide; Germinoma; Humans; Infusions, Intravenous; Male; Middle Aged; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Salvage Therapy; Survival Analysis; Testicular Neoplasms; Treatment Outcome | 2004 |
Weekly gemcitabine, paclitaxel, oxaliplatin combination chemotherapy in patients with Cisplatin-refractory germ cell tumor: preliminary experience.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Resistance, Neoplasm; Female; Gemcitabine; Germinoma; Humans; Male; Mediastinal Neoplasms; Organoplatinum Compounds; Ovarian Neoplasms; Oxaliplatin; Paclitaxel; Survival Analysis; Testicular Neoplasms | 2004 |
Gemcitabine plus cisplatine and paclitaxel (GCP) in second-line treatment of germ cell tumors (GCT): a phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Deoxycytidine; Drug Administration Schedule; Gemcitabine; Germinoma; Humans; Male; Neoplasm Recurrence, Local; Paclitaxel; Testicular Neoplasms; Treatment Outcome | 2005 |
Combination of paclitaxel, ifosfamide, and cisplatin is an effective second-line therapy for patients with relapsed testicular germ cell tumors.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Germinoma; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Patient Selection; Probability; Prognosis; Prospective Studies; Salvage Therapy; Survival Analysis; Testicular Neoplasms; Treatment Outcome | 2005 |
Paclitaxel plus ifosfamide and cisplatin in second-line treatment of germ cell tumors: a phase II study.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Germinoma; Humans; Ifosfamide; Male; Maximum Tolerated Dose; Mediastinal Neoplasms; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Gonadal Tissue; Paclitaxel; Prognosis; Prospective Studies; Retroperitoneal Neoplasms; Salvage Therapy; Testicular Neoplasms; Treatment Outcome | 2005 |
Phase II trial of paclitaxel shows antitumor activity in patients with previously treated germ cell tumors.
Topics: Adolescent; Adult; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Germinoma; Granulocyte Colony-Stimulating Factor; Humans; Male; Mediastinal Neoplasms; Middle Aged; Paclitaxel; Peritoneal Neoplasms; Prognosis; Salvage Therapy; Testicular Neoplasms; Vaginal Neoplasms | 1994 |
Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer.
Topics: Adult; Cisplatin; DNA Damage; Drug Resistance; Germinoma; Humans; Male; Paclitaxel; Testicular Neoplasms | 1994 |
Paclitaxel in salvage therapy for germ cell tumors.
Topics: Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Blood Cells; Carboplatin; Cisplatin; Cohort Studies; Drug Administration Schedule; Drug Resistance, Neoplasm; Etoposide; Follow-Up Studies; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Remission Induction; Salvage Therapy; Stem Cell Transplantation; Testicular Neoplasms; Treatment Outcome | 1997 |
Phase I study of paclitaxel and etoposide for metastatic or recurrent malignancies.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Carcinoma, Small Cell; Drug Administration Schedule; Etoposide; Female; Filgrastim; Germinoma; Granulocyte Colony-Stimulating Factor; Humans; Lung Neoplasms; Male; Middle Aged; Paclitaxel; Recombinant Proteins | 1998 |
Reversible peripheral neuropathy induced by a single administration of high-dose paclitaxel.
Topics: Adult; Breast Neoplasms; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Germinoma; Humans; Infusions, Intravenous; Male; Middle Aged; Paclitaxel; Peripheral Nervous System Diseases; Prospective Studies | 1998 |
Management of intermediate-prognosis germ-cell cancer: results of a phase I/II study of Taxol-BEP.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma; Cisplatin; Etoposide; Germinoma; Humans; Male; Middle Aged; Neoplasm Staging; Neoplasms, Unknown Primary; Paclitaxel; Prognosis; Testicular Neoplasms | 1999 |
Sequential dose-intensive paclitaxel, ifosfamide, carboplatin, and etoposide salvage therapy for germ cell tumor patients.
Topics: Adolescent; Adult; Antineoplastic Combined Chemotherapy Protocols; Area Under Curve; Carboplatin; Drug Administration Schedule; Etoposide; Female; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Ifosfamide; Leukapheresis; Male; Middle Aged; Paclitaxel; Prospective Studies; Salvage Therapy; Survival Analysis | 2000 |
Paclitaxel, ifosfamide, and cisplatin second-line therapy for patients with relapsed testicular germ cell cancer.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Administration Schedule; Germinoma; Granulocyte Colony-Stimulating Factor; Humans; Ifosfamide; Male; Middle Aged; Neoplasm Recurrence, Local; Paclitaxel; Salvage Therapy; Taxoids; Testicular Neoplasms; Treatment Outcome | 2000 |
Phase II study of paclitaxel plus gemcitabine in refractory germ cell tumors (E9897): a trial of the Eastern Cooperative Oncology Group.
Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Drug Administration Schedule; Female; Gemcitabine; Germinoma; Humans; Infusions, Intravenous; Male; Ovarian Neoplasms; Paclitaxel; Seminoma; Testicular Neoplasms; Treatment Outcome; United States | 2002 |
8 other study(ies) available for paclitaxel and Germinoma
Article | Year |
---|---|
Chemotherapy, erythropoietin and bloodless surgery in a Jehovah's Witness.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Aprotinin; Carboplatin; Combined Modality Therapy; Germinoma; Humans; Jehovah's Witnesses; Lung Neoplasms; Male; Paclitaxel | 2003 |
Secondary leukemia after first-line high-dose chemotherapy for patients with advanced germ cell cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Clinical Trials, Phase II as Topic; Etoposide; Follow-Up Studies; Germany; Germinoma; Humans; Ifosfamide; Leukemia, Myeloid, Acute; Male; Mediastinal Neoplasms; Multicenter Studies as Topic; Myelodysplastic Syndromes; Neoplasms, Second Primary; Paclitaxel; Peripheral Blood Stem Cell Transplantation; Testicular Neoplasms; Translocation, Genetic; Transplantation, Autologous | 2005 |
Acute transient encephalopathy following paclitaxel treatment in an adolescent with a recurrent suprasellar germinoma.
Topics: Adolescent; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Brain Diseases; Carboplatin; Cerebral Ventricle Neoplasms; Combined Modality Therapy; Consciousness Disorders; Cranial Irradiation; Cyclophosphamide; Cytarabine; Dacarbazine; Deoxycytidine; Etoposide; Female; Gemcitabine; Germinoma; Hematopoietic Stem Cell Transplantation; Humans; Hypophysectomy; Neoplasm Recurrence, Local; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Pituitary Neoplasms; Temozolomide; Thiotepa; Topotecan | 2008 |
Chemotherapeutic treatment of a pregnant patient with ovarian dysgerminoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Female; Germinoma; Humans; Infant, Newborn; Male; Ovarian Neoplasms; Paclitaxel; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome | 2007 |
Paclitaxel: current developmental approaches of the National Cancer Institute.
Topics: AIDS-Related Opportunistic Infections; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Chemotherapy, Adjuvant; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Combined Modality Therapy; Drug Administration Schedule; Endometrial Neoplasms; Esophageal Neoplasms; Female; Germinoma; Head and Neck Neoplasms; Humans; Lung Neoplasms; National Institutes of Health (U.S.); Ovarian Neoplasms; Paclitaxel; Sarcoma, Kaposi; United States; Urinary Bladder Neoplasms | 1995 |
Phase II study of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancer.
Topics: Adolescent; Adult; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Cisplatin; Clinical Trials, Phase II as Topic; Drug Administration Schedule; Drug Resistance, Neoplasm; Germinoma; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Paclitaxel; Testicular Neoplasms | 1996 |
Pre-clinical activity of taxol in non-seminomatous germ cell tumor cell lines and nude mouse xenografts.
Topics: Animals; Cisplatin; Embryonal Carcinoma Stem Cells; Germinoma; Humans; Ifosfamide; In Vitro Techniques; Mice; Mice, Nude; Neoplasm Transplantation; Neoplastic Stem Cells; Paclitaxel; Transplantation, Heterologous; Tumor Cells, Cultured | 1997 |
Chemotherapy in patients with metastatic or relapsed germ-cell tumours.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Cisplatin; Clinical Trials as Topic; Etoposide; Germinoma; Humans; Ifosfamide; Male; Mediastinal Neoplasms; Neoplasm Recurrence, Local; Paclitaxel; Prognosis; Salvage Therapy; Testicular Neoplasms; Vinblastine | 2001 |